Logo image of IMNM

IMMUNOME INC (IMNM) Stock News

NASDAQ:IMNM - Nasdaq - US45257U1088 - Common Stock - Currency: USD

8.49  +0.03 (+0.35%)

After market: 8.4799 -0.01 (-0.12%)

IMNM Latest News, Press Relases and Analysis

News Image
12 days ago - Zacks Investment Research

Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates

Immunome (IMNM) delivered earnings and revenue surprises of 21.21% and 28.33%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: CDXS

News Image
12 days ago - Zacks Investment Research

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of 14.71% and 19.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: BOLT

News Image
12 days ago - Yahoo Finance

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today

The analyst behind the change is now bullish on Teva's future. A positive change in recommendation from a well-known bank was the fuel propelling Teva Pharmaceutical Industries's (NYSE: TEVA) well higher on Monday. The company, known for being a top producer of generic drugs, saw its share price swell almost 6% as a result.

Mentions: TEVA JPM ENTA PSTV ...

News Image
17 days ago - Zacks Investment Research

Wall Street Analysts Believe Immunome (IMNM) Could Rally 249.93%: Here's is How to Trade

The consensus price target hints at a 249.9% upside potential for Immunome (IMNM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

News Image
5 months ago - MarketBeat

3 Small-Cap Stocks With Big Growth Potential

Small-cap companies may give investors more targeted exposure to the U.S. economy; these companies are three leaders in the space.

Mentions: HNRG NVDA AENT